Hamilton Thorne Ltd. is a public company traded on the Toronto Venture Exchange (TSXV:HTL).
We are a leading global provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets. We market our products and services under the Hamilton Thorne, Gynemed, Planer, and Embryotech Laboratories brands, through our growing direct sales force and distributors worldwide. Our customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments.

Our Brands

HT Logo small transp

Hamilton Thorne manufactures and markets precision laser systems, imaging systems and other equipment and consumables for Assisted Reproductive Technology labs.

Read More

ELI Logo transp

Embryotech provides toxicity testing services and quality control assays for in-house assessment.

Read More

Gynemed logo small transp border

Gynemed manufactures and markets cell culture media, pipettes, and other consumables and equipment for the in vitro fertilization (“IVF”) clinic and laboratory markets.

Read More

planer logo strap AW blu

Planer Ltd. is a leading worldwide provider of products and services that control temperature and other parameters to help customers achieve scientific breakthroughs in biology, medicine and industry.

Read More

TekEvent Logo transp

Tek-Event manufactures and markets Cell-Tek Microscope Chamber, a specialized product for controlling temperature, air flow, humidification, and air quality.

Read More

Gynemed logo small transp border

IVFtech is a company producing advanced equipment for IVF laboratories.

Read More

Microptic

MICROPTIC S.L. is a leading player in the field of research, design, development, sale, installation and service of in-vitro diagnostic systems. Using Artificial Intelligence technology, the company is specialized in semen analysis for over 30 years, both human and animal.

Read More

Subscribe to Our Investor Email List